Dr. Claudia Hesselmann

CEO ARENSIA Exploratory Medicine GmbH, Germany
Dr. Claudia Hesselmann

Claudia Hesselmann, chemist by training with PhD in molecular biology, has over 15 years of expertise in the early phases of drug development. This includes co-founding and holding management positions in various CROs with activities in Western and Eastern Europe, Japan and Middle East. With such extensive experience and based on long-time networking in the

Pharmaceutical industry, Claudia has co-founded ARENSIA Exploratory Medicine in Düsseldorf, Germany, with the purpose of contributing with innovative strategies to the acceleration of the drug development process. ARENSIA runs its own network of modern Phase I units, located in large hospitals in Eastern Europe. The units are specialized to perform sophisticated Phase Ib/IIa/Proof-of-Concept trials in PATIENTS, with extraordinary recruitment speed across most therapeutic areas.

Go back to Agenda & Venue

CONTACT

For more information about your participation, please contact us at info@clinicaltrialsymposium.com or call us at +40 (0) 721 884 421

For additional information regarding partnership, sponsors & exhibitors and media, please contact our
marketing and communication department at anca.bejenaru@clinicaltrialsymposium.com or +40 (0) 726 840 456 +40 (0) 742 231 001

STAY CONNECTED

Subscribe to our newsletter and stay connected to news about
our symposium and AVANTYO Institute of Clinical Research!

Clinical Trials Symposium is an event organized by Avantyo Institute of Clinical Research - www.avantyo.com